NEW YORK – November 19th, 2025 – Nym, a leader in autonomous medical coding, today announced that it has been named to The Healthcare Technology Report’s Top 50 Healthcare Technology Companies of 2025. The annual list recognizes healthcare technology companies advancing solutions that strengthen care quality and operational performance across the industry.
The leading online resource for investors, executives, and professionals in the healthcare technology industry, The Healthcare Technology Report is renowned for its in-depth reports and insights on companies that are driving innovation and growth in the sector. The Healthcare Technology Report’s 2025 list highlights companies making significant advances across digital care delivery, clinical insights, data platforms, and next-generation therapeutics. This year’s awardees demonstrated how healthcare technology can deepen its impact through intelligent automation, precision medicine, and platform innovations that improve both clinical and operational outcomes.
“We’re honored to be recognized alongside innovators who are transforming healthcare delivery, diagnostics, and clinical intelligence,” said Or Peles, CEO of Nym Health. “This recognition reflects our team’s commitment to autonomous medical coding technology that empowers revenue cycle and health information management professionals and eases the administrative burden on healthcare provider organizations.”
Nym’s autonomous medical coding engine assigns codes to patient encounters in seconds with unprecedented accuracy and zero human intervention while providing complete transparency and audit trails for every coding decision. Supporting six different specialties and service lines, including emergency medicine, radiology, and outpatient surgery, Nym’s engine is a true multispecialty solution. Health systems and physician groups that implement autonomous coding with Nym achieve significant reductions in coding costs, faster time-to-bill, more accurate revenue capture, and reduced administrative burden.
About Nym
Nym is the leader in transforming clinical language into actionable information, which can remove inefficiencies that add billions to the cost of care. By combining industry-leading technology with clinical expertise and a deep understanding of medical language, Nym is able to accurately decode medical charts in a way that is fast, explainable, and compliant across multiple specialties in both outpatient and inpatient care settings. The Nym engine translates provider notes within patient charts into diagnostic and billing charge codes in a matter of seconds, with over 95 percent accuracy and absolutely zero human intervention. Nym’s medical coding engine also delivers audit-ready, traceable documentation for every code it generates, ensuring total visibility into coding rationale. Nym’s solution can be quickly deployed and scaled based on volume and workflow needs, easing administrative burdens and allowing clinical teams to spend more time focused on patient care.
Based in New York City with R&D capabilities in Tel Aviv, Nym is building an interdisciplinary team of specialists including technologists, physicians, mathematicians, computational linguists, engineers, medical coders and more. Investors in Nym include PSG, Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, Tiger Global, Zach Weinberg and Nat Turner. To learn more about Nym, visit nym.health.
Media Contact: Nicole Pariser | moc.htlaehmyn@elocin